Comparative transcriptome analysis of Peromyscus leucopus and C3H mice infected with the Lyme disease pathogen

Lyme disease (LD), the most prevalent tick-borne disease of humans in the Northern Hemisphere, is caused by the spirochetal bacterium of Borreliella burgdorferi (Bb) sensu lato complex. In nature, Bb spirochetes are continuously transmitted between Ixodes ticks and mammalian or avian reservoir hosts. Peromyscus leucopus mice are considered the primary mammalian reservoir of Bb in the United States. Earlier studies demonstrated that experimentally infected P. leucopus mice do not develop disease. In contrast, C3H mice, a widely used laboratory strain of Mus musculus in the LD field, develop severe Lyme arthritis. To date, the exact tolerance mechanism of P. leucopus mice to Bb-induced infection remains unknown. To address this knowledge gap, the present study has compared spleen transcriptomes of P. leucopus and C3H/HeJ mice infected with Bb strain 297 with those of their respective uninfected controls. Overall, the data showed that the spleen transcriptome of Bb-infected P. leucopus mice was much more quiescent compared to that of the infected C3H mice. To date, the current investigation is one of the few that have examined the transcriptome response of natural reservoir hosts to Borreliella infection. Although the experimental design of this study significantly differed from those of two previous investigations, the collective results of the current and published studies have consistently demonstrated very limited transcriptomic responses of different reservoir hosts to the persistent infection of LD pathogens. Importance The bacterium Borreliella burgdorferi (Bb) causes Lyme disease, which is one of the emerging and highly debilitating human diseases in countries of the Northern Hemisphere. In nature, Bb spirochetes are maintained between hard ticks of Ixodes spp. and mammals or birds. In the United States, the white-footed mouse, Peromyscus leucopus, is one of the main Bb reservoirs. In contrast to humans and laboratory mice (e.g., C3H mice), white-footed mice rarely develop clinical signs (disease) despite being (persistently) infected with Bb. How the white-footed mouse tolerates Bb infection is the question that the present study has attempted to address. Comparisons of genetic responses between Bb-infected and uninfected mice demonstrated that, during a long-term Bb infection, C3H mice reacted much stronger, whereas P. leucopus mice were relatively unresponsive.

[1]  Paul Theodor Pyl,et al.  Analysing high-throughput sequencing data in Python with HTSeq 2.0 , 2021, Bioinform..

[2]  Nadezhda T. Doncheva,et al.  Correction to ‘The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets’ , 2021, Nucleic acids research.

[3]  A. Steere,et al.  Lyme arthritis: linking infection, inflammation and autoimmunity , 2021, Nature Reviews Rheumatology.

[4]  Radhey S. Gupta,et al.  The Family Borreliaceae (Spirochaetales), a Diverse Group in Two Genera of Tick-Borne Spirochetes of Mammals, Birds, and Reptiles , 2021, Journal of Medical Entomology.

[5]  A. Mortazavi,et al.  An Infection-Tolerant Mammalian Reservoir for Several Zoonotic Agents Broadly Counters the Inflammatory Effects of Endotoxin , 2021, mBio.

[6]  A. Hinckley,et al.  Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018 , 2021, Emerging infectious diseases.

[7]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[8]  F. Strle,et al.  Lyme Disease in Humans. , 2020, Current issues in molecular biology.

[9]  R. M. Wooten,et al.  Immune Response to Borrelia: Lessons from Lyme Disease Spirochetes. , 2020, Current issues in molecular biology.

[10]  E. Fliers,et al.  The Role of Thyroid Hormone in the Innate and Adaptive Immune Response during Infection. , 2020, Comprehensive Physiology.

[11]  M. Lundberg,et al.  Comparison of spleen transcriptomes of two wild rodent species reveals differences in the immune response against Borrelia afzelii , 2020, Ecology and evolution.

[12]  Thawfeek M. Varusai,et al.  The reactome pathway knowledgebase , 2019, Nucleic Acids Res..

[13]  James G. Baldwin-Brown,et al.  The genome of Peromyscus leucopus, natural host for Lyme disease and other emerging infections , 2019, Science Advances.

[14]  S. Mane,et al.  CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation , 2019, Nature Genetics.

[15]  L. Råberg,et al.  Colonization and pathology of Borrelia afzelii in its natural hosts. , 2019, Ticks and tick-borne diseases.

[16]  S. Jirawatnotai,et al.  Immunomodulatory Roles of Cell Cycle Regulators , 2019, Front. Cell Dev. Biol..

[17]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[18]  M. Philipp,et al.  Intracellular TLR7 is activated in human oligodendrocytes in response to Borrelia burgdorferi exposure , 2018, Neuroscience Letters.

[19]  Thawfeek M. Varusai,et al.  The Reactome Pathway Knowledgebase , 2017, Nucleic acids research.

[20]  Lincoln Stein,et al.  Reactome enhanced pathway visualization , 2017, Bioinform..

[21]  M. Oosting,et al.  The role of host immune cells and Borrelia burgdorferi antigens in the etiology of Lyme disease , 2017, European Cytokine Network.

[22]  A. Zelikovsky,et al.  Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion , 2016, Infection and Immunity.

[23]  Andrea C. Love,et al.  Borrelia burgdorferi induces a type I interferon response during early stages of disseminated infection in mice , 2016, BMC Microbiology.

[24]  A. Barbour,et al.  Broad diversity of host responses of the white-footed mouse Peromyscus leucopus to Borrelia infection and antigens. , 2015, Ticks and tick-borne diseases.

[25]  P. Mead Epidemiology of Lyme disease. , 2015, Infectious disease clinics of North America.

[26]  T. Bankhead,et al.  Evaluation of the Importance of VlsE Antigenic Variation for the Enzootic Cycle of Borrelia burgdorferi , 2015, PloS one.

[27]  Sky W. Brubaker,et al.  Innate immune pattern recognition: a cell biological perspective. , 2015, Annual review of immunology.

[28]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[29]  U. Pal,et al.  Strain-Specific Variation of the Decorin-Binding Adhesin DbpA Influences the Tissue Tropism of the Lyme Disease Spirochete , 2014, PLoS pathogens.

[30]  Andrea C. Love,et al.  Borrelia burgdorferi RNA Induces Type I and III Interferons via Toll-Like Receptor 7 and Contributes to Production of NF-κB-Dependent Cytokines , 2014, Infection and Immunity.

[31]  S. Barthold,et al.  MyD88- and TRIF-Independent Induction of Type I Interferon Drives Naive B Cell Accumulation but Not Loss of Lymph Node Architecture in Lyme Disease , 2014, Infection and Immunity.

[32]  M. Pittet,et al.  The spleen in local and systemic regulation of immunity. , 2013, Immunity.

[33]  E. Parisini,et al.  Ly6 family proteins in neutrophil biology , 2013, Journal of leukocyte biology.

[34]  Karin Breuer,et al.  InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation , 2012, Nucleic Acids Res..

[35]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[36]  A. Barbour,et al.  Experimental Infections of the Reservoir Species Peromyscus leucopus with Diverse Strains of Borrelia burgdorferi, a Lyme Disease Agent , 2012, mBio.

[37]  Xin Li,et al.  TRIF Mediates Toll-Like Receptor 2-Dependent Inflammatory Responses to Borrelia burgdorferi , 2012, Infection and Immunity.

[38]  L. Råberg Infection intensity and infectivity of the tick‐borne pathogen Borrelia afzelii , 2012, Journal of evolutionary biology.

[39]  J. Zachary,et al.  Localized Production of IL-10 Suppresses Early Inflammatory Cell Infiltration and Subsequent Development of IFN-γ–Mediated Lyme Arthritis , 2012, The Journal of Immunology.

[40]  Huanbin Xu,et al.  Bone marrow and the control of immunity , 2011, Cellular and Molecular Immunology.

[41]  Brian G Smith,et al.  Lyme Disease and the Orthopaedic Implications of Lyme Arthritis , 2011, The Journal of the American Academy of Orthopaedic Surgeons.

[42]  R. Ostfeld,et al.  Borrelia burgdorferi has minimal impact on the Lyme disease reservoir host Peromyscus leucopus. , 2011, Vector borne and zoonotic diseases.

[43]  S. Akira,et al.  HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses , 2009, Nature.

[44]  I. Schwartz,et al.  Recognition of Borrelia burgdorferi, the Lyme Disease Spirochete, by TLR7 and TLR9 Induces a Type I IFN Response by Human Immune Cells1 , 2009, The Journal of Immunology.

[45]  S. Akira,et al.  Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells , 2009, Nature Immunology.

[46]  J. Zachary,et al.  A Critical Role for Type I IFN in Arthritis Development following Borrelia burgdorferi Infection of Mice1 , 2008, The Journal of Immunology.

[47]  S. Akira,et al.  Distinct Roles for MyD88 and Toll-Like Receptors 2, 5, and 9 in Phagocytosis of Borrelia burgdorferi and Cytokine Induction , 2008, Infection and Immunity.

[48]  D. Fish,et al.  Fitness Variation of Borrelia burgdorferi Sensu Stricto Strains in Mice , 2007, Applied and Environmental Microbiology.

[49]  R. M. Wooten,et al.  Gene Expression Profiling Reveals Unique Pathways Associated with Differential Severity of Lyme Arthritis1 , 2006, The Journal of Immunology.

[50]  D. Fish,et al.  Fundamental processes in the evolutionary ecology of Lyme borreliosis , 2006, Nature Reviews Microbiology.

[51]  T. Visser,et al.  Thyroid hormone transporters. , 2005, Biochemical Society Transactions.

[52]  Christian von Mering,et al.  STRING: known and predicted protein–protein associations, integrated and transferred across organisms , 2004, Nucleic Acids Res..

[53]  J. Piesman,et al.  Lyme borreliosis in Europe and North America , 2004, Parasitology.

[54]  S. Akira,et al.  MyD88 Plays a Unique Role in Host Defense but Not Arthritis Development in Lyme Disease1 , 2004, The Journal of Immunology.

[55]  T. Visser,et al.  Identification of Monocarboxylate Transporter 8 as a Specific Thyroid Hormone Transporter* , 2003, Journal of Biological Chemistry.

[56]  R. M. Wooten,et al.  Toll-Like Receptor 2 Is Required for Innate, But Not Acquired, Host Defense to Borrelia burgdorferi1 , 2002, The Journal of Immunology.

[57]  R. M. Wooten,et al.  Toll-like receptor 2 plays a pivotal role in host defense and inflammatory response to Borrelia burgdorferi. , 2002, Vector borne and zoonotic diseases.

[58]  R. M. Wooten,et al.  Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. , 2001, Current opinion in microbiology.

[59]  V. Dennis,et al.  Early Induction of Gamma Interferon and Interleukin-10 Production in Draining Lymph Nodes from Mice Infected withBorrelia burgdorferi , 2000, Infection and Immunity.

[60]  S. Barthold,et al.  T-Cell-Independent Responses to Borrelia burgdorferiAre Critical for Protective Immunity and Resolution of Lyme Disease , 2000, Infection and Immunity.

[61]  R. M. Wooten,et al.  Dual Role of Interleukin-10 in Murine Lyme Disease: Regulation of Arthritis Severity and Host Defense , 1999, Infection and Immunity.

[62]  R. M. Wooten,et al.  Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. , 1999, Journal of immunology.

[63]  Charles R. Brown,et al.  Experimental Lyme Arthritis in the Absence of Interleukin-4 or Gamma Interferon , 1999, Infection and Immunity.

[64]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[65]  C. Teuscher,et al.  Distinct Characteristics of Resistance toBorrelia burgdorferi-Induced Arthritis in C57BL/6N Mice , 1998, Infection and Immunity.

[66]  E. Fikrig,et al.  Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[67]  K. Ebnet,et al.  Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. , 1997, Journal of immunology.

[68]  R. M. Wooten,et al.  Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-kappa B and inflammatory activation in human endothelial cells. , 1996, Journal of immunology.

[69]  P. Borrow,et al.  CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response , 1996, The Journal of experimental medicine.

[70]  J. Banchereau,et al.  CD40-CD40 ligand: a multifunctional receptor-ligand pair. , 1996, Advances in immunology.

[71]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[72]  S. Barthold,et al.  EXPERIMENTAL BORRELIA BURGDORFERI INFECTION IN PEROMYSCUS LEUCOPUS , 1994, Journal of wildlife diseases.

[73]  G. Baranton,et al.  Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. , 1993, Scandinavian journal of infectious diseases.

[74]  S. Barthold,et al.  Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. , 1992, The American journal of tropical medicine and hygiene.

[75]  D. Persing,et al.  Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. , 1992, The American journal of tropical medicine and hygiene.

[76]  G. Baranton,et al.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. , 1992, International journal of systematic bacteriology.

[77]  E. Clark,et al.  Molecular and biological characterization of a murine ligand for CD40 , 1992, Nature.

[78]  S. Barthold,et al.  Lyme borreliosis in selected strains and ages of laboratory mice. , 1990, The Journal of infectious diseases.

[79]  J. French,et al.  Systemic disease in Peromyscus leucopus associated with Borrelia burgdorferi infection. , 1990, The American journal of tropical medicine and hygiene.

[80]  T. Schwan,et al.  Antibody response in white-footed mice (Peromyscus leucopus) experimentally infected with the Lyme disease spirochete (Borrelia burgdorferi) , 1989, Infection and immunity.

[81]  J. Benach,et al.  Immunoglobulin G Subclasses Specific to Borrelia burgdorferi in Patients with Lyme Disease , 1988, Annals of the New York Academy of Sciences.

[82]  F. Dumont,et al.  Ly‐6 A/E antigen of murine T cells is associated with a distinct pathway of activation. Requirements for interferon and exogenous interleukin 2 , 1988, European journal of immunology.

[83]  K. Takayama,et al.  Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi , 1987, Infection and immunity.

[84]  A. Spielman,et al.  Reservoir competence of white-footed mice for Lyme disease spirochetes. , 1987, The American journal of tropical medicine and hygiene.

[85]  E. Shevach,et al.  Role of Ly-6 in lymphocyte activation. I. Characterization of a monoclonal antibody to a nonpolymorphic Ly-6 specificity. , 1986, Journal of immunology.

[86]  A. Spielman,et al.  Mice as reservoirs of the Lyme disease spirochete. , 1985, The American journal of tropical medicine and hygiene.